Skip to content
DataLookout
Menu

TOWARNCT04684719

Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial

StatusCompleted
PhasePhase 3
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 21 versions: 18 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Results posted: Nov 19, 2026 Show 5 more changesShow less
    • Eligibility criteria shortened, about 12 words
    • Interventions: Standard Care (Biological), low titer whole blood (Biological) to component transfusion (Biological), low titer whole blood (Biological)
    • Secondary endpoints: 20 to 12
    • Primary endpoint revised
    • Publications: details revised at 3 of 3 entries
  2. Minor Trial status: Active, Not Recruiting to Completed
    • Study completion date changed from estimate of Sep 2025 to Aug 12, 2025
    v19
  3. Minor Primary completion date changed from estimate of Jul 2025 to Jul 28, 2025v18
  4. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 10 of 10 sites
    v17
  5. Minor Site contacts updated at 3 of 10 sitesv16
Show 12 earlier versionsHide 12 earlier versions
  1. Minor Site details revised at 5 of 10 sitesv15
  2. Minor Study sites: 8 to 10v13
  3. Notable Phase: Phase 2 to Phase 3v12
  4. Minor Study sites: 7 to 8v11
  5. Minor Study sites: 6 to 7v10
  6. Minor Study sites: 4 to 6v9
  7. Minor Study sites: 3 to 4v8
  8. Notable Eligibility criteria expanded, about 7 words
    • Study sites: 2 to 3
    v7
  9. Minor Study sites: 1 to 2v5
  10. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jun 2022 to Apr 19, 2022
    • Secondary endpoints: 19 to 20
    • Site details revised
    v4
  11. Notable Eligibility criteria expanded, about 3 wordsv3
  12. Notable Start date: Jun 2021 to Jun 2022v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

30 Day Mortality
Timeframe: thru 30 days of enrollment

Secondary (12)

3-hour Mortality
6-hour Mortality
24-hour Mortality
In-hospital Mortality
Blood and Blood Component Transfusion Amount
Show 7 moreShow less
Multiple Organ Failure (MOF)
Hospital-acquired Pneumonia
Blood Stream Infection
Acute Respiratory Distress Syndrome (ARDS)
Abnormal International Normalized Ratio (INR)
Achievement of Hemostasis
Transfusion Reaction

Arms and interventions

Whole BloodExperimental

Subjects will receive up to two units of whole blood as collected by local blood bank procedures and stored at 1-6 degrees Celsius initiated in the prehospital phase of care.

Component transfusionActive comparator

Subjects will receive prehospital crystalloid infusion or blood component transfusion resuscitation per site standard care for the respective Emergency Medical unit/service.

Biologicals: low titer whole blood, component transfusion

Sites

10 sites in 1 country